Parameters related to lipid metabolism as markers of myelination in mouse brain.
Myelination, during both normal development and with respect to disorders of myelination, is commonly studied by morphological and/or biochemical techniques that assay as their end-points the extent of myelination. The rate of myelination is potentially a more useful parameter, but it is difficult and time-consuming to establish, requiring a complete developmental study with labor-intensive methodology. We report herein development of methodology to assay the absolute rate of myelination at any desired time during development. This involves intraperitoneal injection of (3)H(2)O to label body water pools, followed by determination of label in the myelin-specific lipid, cerebroside. The absolute amount of cerebroside synthesized can then be calculated from the specific radioactivity of body water and knowledge of the number of hydrogens from water incorporated into cerebroside. During development, the rate of cerebroside synthesis correlated well with the rate of accumulation of the myelin-specific components, myelin basic protein and cerebroside. For purposes of control, we also tested other putative, albeit less quantitative, indices of the rate of myelination. Levels of mRNA for ceramide galactosyltransferase (rate-limiting enzyme in cerebroside synthesis) and for myelin basic protein did not closely correlate with myelination at all times. Cholesterol synthesis closely matched the rate of cholesterol accumulation but did not track well with myelination. Synthesis of fatty acids did not correlate well with accumulation of either fatty acids (phospholipids) or myelin markers. We conclude that measurement of cerebroside synthesis rates provides a good measure of the rate of myelination. This approach may be useful as an additional parameter for examining the effects of environmental or genetic alterations on the rate of myelination.
Muse
E D
ED
Neuroscience Center, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA.
Jurevics
H
H
Toews
A D
AD
Matsushima
G K
GK
Morell
P
P
D000375:Aging / Q000378:metabolism; D000818:Animals; D015415:Biomarkers; D001834:Body Water / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002554:Cerebrosides / Q000032:analysis / Q000096:biosynthesis; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism; D005227:Fatty Acids / Q000032:analysis / Q000096:biosynthesis; D005260:Female; D005700:Galactosyltransferases / Q000235:genetics / Q000378:metabolism; D006903:Hydroxymethylglutaryl CoA Reductases / Q000235:genetics / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D004676:Myelin Basic Protein / Q000235:genetics / Q000378:metabolism; D009186:Myelin Sheath / Q000378:metabolism*; D051146:N-Acylsphingosine Galactosyltransferase; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D014316:Tritium
D015415:Biomarkers; D002554:Cerebrosides; D005227:Fatty Acids; D008055:Lipids; D004676:Myelin Basic Protein; D012333:RNA, Messenger; D014316:Tritium; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D005700:Galactosyltransferases; D051146:N-Acylsphingosine Galactosyltransferase